IL2 and oligoarticular juvenile idiopathic arthritis: Upregulation of the IL-2-pathway suggests a role for anti-T cell strategies such as JAK-STAT inhibitors or cyclosporine in some refractory polyarticular/oligoarticular JIA patients.